Botulinum Toxin A for Plantar Fasciitis: A Review
Author Information
Author(s): Li Qian, Zhang Jing, Sun Jie, Gao Chengfei, Zhao Jing
Primary Institution: Department of Rehabilitation Medicine, Zibo Central Hospital, Zibo, Shandong, China
Hypothesis
The study aims to evaluate the therapeutic efficacy and safety of botulinum toxin A injections for treating plantar fasciitis.
Conclusion
Botulinum toxin A injections can effectively reduce pain and improve function in patients with plantar fasciitis without significant adverse events.
Supporting Evidence
- BTA injections led to significant pain reduction at 1-month posttreatment.
- Functional improvement was sustained over twelve months.
- No serious adverse events were reported in the included studies.
- Only mild and temporary treatment-related adverse events were noted.
- Seven randomized controlled trials were included in the meta-analysis.
- Participants' ages ranged from 21 to 77 years.
- More females than males participated in the studies.
Takeaway
This study found that a special injection can help people with foot pain feel better and move better.
Methodology
A systematic review and meta-analysis of randomized controlled trials comparing BTA injections with control interventions.
Potential Biases
Several studies had methodological flaws, including unclear randomization and allocation concealment.
Limitations
The review included only seven studies, which may limit the statistical power and generalizability of the findings.
Participant Demographics
Participants included 305 patients with plantar fasciitis, predominantly female (214 females and 91 males), aged 21 to 77 years.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI [-3.10, -0.34]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website